RCKT Rocket Pharmaceuticals, Inc.
$3.35▼ -3.74%
Healthcare
Other
After hours
$3.29▼ -1.79%
Sep 11, 7:30 PM ET
Volume 1.66M
Avg Volume (10D) 1.32M
Key Metrics & Fundamentals
Market Cap
$367.74M
P/E Ratio
–
Div Yield
–%
52W Range
2.53 - 5.45
% vs 50 MA
-6.09%
% vs 200 MA
-6.68%
RSI-14
41.7
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.88
Free Cash Flow
-$39.62M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$43.78M
COGS
–
Operating Exp
$46.92M
Operating Income
-$46.92M
EBIT
-$46.92M
Pretax Income
$131.84M
Net Income
$123.21M
EPS (Diluted)
1.08
Price & Volume History
Loading chart…
Recent News
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 11, 2026 3:30 PM
Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?
Zacks · Sep 10, 2026 3:30 PM
Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue?
Zacks · Sep 9, 2026 3:30 PM
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Wire · Sep 3, 2026 11:00 AM
Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus
Zacks · Aug 11, 2026 6:21 PM
Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says
MT Newswires · Aug 11, 2026 5:36 PM
Wedbush Adjusts PT on Rocket Pharmaceuticals to $15 From $16, Keeps Outperform Rating
MT Newswires · Aug 11, 2026 12:15 PM
Rocket Pharmaceuticals: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 10:15 PM
Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
Business Wire · Aug 10, 2026 8:00 PM
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
Business Wire · Aug 3, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RCKT's money flow as a full page
Social Sentiment
Avg +0.92 · 4 posts
NewsDDTradeRocket Pharmaceuticals (RCKT) Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
r/wallstreetbets · Mar 27, 2026
The post announces FDA approval, a highly positive event for the company. The comments also indicate a pump and dump situation.
very_positive
+1.00
NewsDiscussionTradeRocket pharmaceuticals gets FDA approval (RCKT)
r/investing · Mar 27, 2026
The post expresses excitement about the FDA approval and anticipates a potential price jump, indicating a bullish sentiment.
positive
+0.80
NewsTradeRocket pharmaceuticals gets FDA approval (RCKT)
r/wallstreetbets · Mar 27, 2026
The post is celebrating FDA approval, a highly positive event for the company.
very_positive
+1.00
DDTradeNewsRCKT FDA APPROVAL AFTER HOURS LOOKIJG TO RUN IN PREMARKET
r/wallstreetbets · Mar 27, 2026
The post expresses strong optimism regarding RCKT's approval, potential gains, and financial health, using bullish language and emojis.
very_positive
+0.90
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.